Narrator: This is Science Today. In an effort to help curb the HIV epidemic in California, research funds provided by the University of California have been granted to statewide investigators to test a potential HIV prevention pill among high-risk, uninfected people in several California communities. Dr. George Lemp, director of UC's California HIV/AIDS Research Program, says the unique initiative is part of an Epidemic Interventions Demonstration Project.
Lemp: The purpose of the initiative is to impact the epidemic of HIV/AIDS in California through a series of projects that will intervene in the transmission of HIV infection and also improve people's access to HIV/AIDS care and treatment.
Narrator: The initiative is testing a drug called Truvada, which is currently used to treat people with HIV infection. In this case, it will be given to uninfected people at high-risk of the disease.
Lemp: It's manufactured by Gilead Sciences and they're providing the drug free of charge to the participants in this particular demonstration project.
Narrator: For Science Today, I'm Larissa Branin.